PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
100 hedge funds and large institutions have $193M invested in Aratana Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 105 → 100 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
100
Holding in Top 10
3
Calls
$482K
Puts
$6K
Top Buyers
| 1 | +$9.72M | |
| 2 | +$2.87M | |
| 3 | +$1.5M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.22M |
| 5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$828K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$1.39M | |
| 3 | -$1.23M | |
| 4 |
Renaissance Technologies
New York
|
-$685K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$584K |